OpenAlex
PricingAboutJobs
Log inGet started
Work

Solanezumab for the treatment of mild-to-moderate Alzheimer’s disease

HTML

Year: 2012
Type: review
Source: Expert Review of Clinical Immunology
DOI: 10.1586/eci.11.93
Authors: Bruno P Imbimbo, Simone Ottonello, Vincenza Frisardi, Vincenzo Solfrizzi, Antonio Greco, Davide Seripa, Alberto Pilotto, Francesco Panza
Institutions: Chiesi (Italy), University of Parma, Casa Sollievo della Sofferenza, University of Bari Aldo Moro, Ospedale Sant Antonio
Language: English

Topic: Alzheimer's disease research and treatments
Subfield: Cellular and Molecular Neuroscience
Field: Neuroscience
Domain: Life Sciences
Keywords: solanezumab, Alzheimer's disease, amyloid-beta, monoclonal antibodies, passive immunotherapy, anti-amyloid therapy, cerebral amyloid angiopathy, microhemorrhages, bapineuzumab, memory impairment, cerebrospinal fluid biomarkers, plasma biomarkers, drug safety, disease progression
SDG: Good health and well-being

Open Access status: closed
OpenAlex ID: W2142922534
FWCI: 1.143
Cites: 81
Cited by: 105
Related to: 10
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Subscribe
Supporters
Legal
Privacy
Accessibility
Terms
Security